Page last updated: 2024-09-03

2-azidoadenosine 3',5'-diphosphate and alprostadil

2-azidoadenosine 3',5'-diphosphate has been researched along with alprostadil in 1 studies

Compound Research Comparison

Studies
(2-azidoadenosine 3',5'-diphosphate)
Trials
(2-azidoadenosine 3',5'-diphosphate)
Recent Studies (post-2010)
(2-azidoadenosine 3',5'-diphosphate)
Studies
(alprostadil)
Trials
(alprostadil)
Recent Studies (post-2010) (alprostadil)
34007,136864761

Protein Interaction Comparison

ProteinTaxonomy2-azidoadenosine 3',5'-diphosphate (IC50)alprostadil (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)2.3
Solute carrier organic anion transporter family member 2B1Rattus norvegicus (Norway rat)0.0358

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Macfarlane, DE; Mills, DC; Srivastava, PC1

Other Studies

1 other study(ies) available for 2-azidoadenosine 3',5'-diphosphate and alprostadil

ArticleYear
Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Biochemistry, 1982, Feb-02, Volume: 21, Issue:3

    Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Azides; Binding Sites; Blood Platelets; Cell Membrane; Cyclic AMP; Humans; Kinetics; Phosphorus Radioisotopes; Platelet Aggregation; Prostaglandins E; Spectrophotometry, Ultraviolet

1982